Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: Physiologic implications and new opportunities in biologic monitoring

Environmental Health Perspectives

Volumn 108, Issue 1, 2000, Pages 29-33

  Coccini, Teresa ^a,e   Randine, Giovanna ^b   Candura, Stefano M ^a,c   Nappi, Rossella E ^b,c   Prockop, Leon D ^d   Manzo, Luigi ^a,c  

^a IRCCS   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e Found Med Ctr   (Italy)

Author keywords

Biomarker; Brain; Cholinergic system; Lymphocyte; Methylmercury; Muscarinic receptor; Neurotoxicity

Indexed keywords

BRAIN RECEPTOR; LYMPHOCYTE RECEPTOR; METHYLMERCURY; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; BRAIN; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HIPPOCAMPUS; LYMPHOCYTE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SPLEEN LYMPHOCYTE;

ANIMALIA;

EID: 0033955331     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.0010829     Document Type: Article

References (52)

1. Takeuchi T, Human effects of methylmercury as an environmental neurotoxicant. In: Neurotoxicology (Blum K, Manzo L, eds). NewYork:Marcel Dekker, 1975:345-367.
2. Davis LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW, Cernichiari E, Clarkson TW. Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol 35:680-688 (1994).
3. Myers GJ, Davidson PW, Cox C, Shamlaye CF, Tanner MA, Marsh DO, Cernichiari E, Lapham LW, Berlin M, Clarkson TW. Summary of the Seychelles child development study on the relationship of fetal methylmercury exposure to neurodevelopment. Neurotoxicology 16:711-716 (1995).
4. Wheeler M. Measuring mercury. Environ Health Perspect 104:826-831 (1996).
5. Boischio AAP, Henshel DS. Risk assessment of mercury exposure through fish consumption by the riverside people in the Madeira Basin, Amazon, 1991. Neurotoxicology 17:169-176 (1996).
6. Watanabe C, Satoh H. Evolution of our understanding of methylmercury as a health threat. Environ Health Perspect 104(suppl 2):367-379 (1996).
7. Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, Murata K, Sorensen N, Dahl R, Jorgensen PJ. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19:417-428 (1997).
8. Yuan Y, Atchison WD. Disruption by methylmercury of membrane excitability and synaplic transmission of CA1 neurons in hippocampal slices of the rat. Toxicol Appl Pharmacol 120:203-215 (1993).
9. Candura SM, D'Agostino G, Castoldi AF, Messori E, Liuzzi M, Manzo L, Tonini M. Effects of mercuric chloride and methyl mercury on cholinergic neuromuscular transmission in the guinea-pig ileum. Pharmacol Toxicol 80:218-224 (1997).
10. Eldefrawi ME, Mansour NA, Eldefrawi AT. Interactions of acetylcholine receptors with organic mercury compounds. Adv Exp Med Biol 84:449-463 (1977).
11. Von Burg R, Northington EK, Shamoo A, Methylmercury inhibition of rat brain muscarinic receptors. Toxicol Appl Pharmacol 53:285-292 (1980).
12. Castoldi AF, Candura SM, Costa P, Manzo L, Costa LG. Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. Neurotoxicology 17:735-742 (1996).
13. Tsuzuki Y. Effects of chronic methylmercury exposure on activities of neurotransmitter enzymes in rat cerebellum. Toxicol Appl Pharmacol 60:379-381 (1981).
14. Hrdina PD, Peters DAV, Singhal RL Effects of chronic exposure to cadmium, lead, and mercury on brain biogenic amines in the rat. Res Commun Chem Pathol Pharmacol 15:483-493 (1976).
15. Kobayashi H, Yuyama A, Matsusaka N, Takeno K, Yanagiya I. Effect of methylmercury on brain acetylcholine concentration and turnover in mice. Toxicol Appl Pharmacol 54:1-8 (1980).
16. Zanoli P, Truzzi C, Veneri C, Braghiroli D, Baraldi M. Methyl mercury during late gestation affects temporarily the development of cortical muscarinic receptors in rat offspring. Pharmacol Toxicol 75:261-264 (1994).
17. Strom TB, Sytkowski AT, Carpenter CB, Merril JP. Cholinergic augmentation of lymphocyte-mediated cytotoxicity. A study of the cholinergic receptors of cytotoxic T lymphocytes. Proc Natl Acad Sci 71:1330-1333 (1974).
18. Maslinski W, Kullberg M, Nordstrom O, Bartfai T. Muscarinic receptors and receptor-mediated actions on rat thymocytes. J Neuroimmunol 17:265-274 (1988).
19. 3H]N-methylscopolamine binding to muscannic receptors in human peripheral blood lymphocytes: characterization, localization on T lymphocyte subsets and age-dependent changes Neuropharmacology 28:719-726 (1989).
20. Bronzetti E, Adani O, Amenta F, Felici L, Mannino F, Ricci A. Muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. Neurosci Lett 208:211-215 (1996).
21. Costa LG, Kaylor G, Murphy SD. Muscarinic cholinergic binding sites on rat lymphocytes. Immunopharmacology 16:139-149 (1988).
22. Costa LG, Kaylor G, Murphy SD. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents, Int J Immunopharmacol 12:67-75 (1990).
23. Fitzgerald BB, Costa LG. Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. Fundam Appl Toxicol 20:210-216 (1993).
24. Rabey JM, Lewis A, Graff E, Korczyn AD. Decreased (3H) quinuclidinyl benzylate binding to lymphocytes in Gilles de la Tourette syndrome. Biol Psychiatry 31:889-895 (1992).
25. Masuyama K, Uno K, Minoda R, Eura M, Samejima Y, Ishikawa T. Muscarinic acetylcholine receptors on human lymphocytes in patients with Meniere's disease. Acta Otolaryngol 116:369-373 (1996).
26. Shenker BJ. Guo TL, Shapiro IM. Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res 77:149-159 (1998).
27. Nagashima K. A review of experimental methylmercury toxicity in rats: neuropathology and evidence for apoptosis. Toxicol Pathol 25:624-631 (1997).
28. European Council. Council directive of 24 November 1986 on the approximateion of laws, regulations, and administrative provisions of the Member States regarding the protection of animals used for experimental and scientific purposes. Off J Eur Communities 1358:1-28 (1986).
29. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(suppl 97):77-89 (1968).
30. Yamamura HI, Snyder SH. Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725-1729 (1974).
31. Costa LG, Kaylor G, Murphy SD. Carbachol-and norepinephrine-stimulated phosphoinositide metabolism in rat brain: effect of chronic cholinesterase inhibition. J Pharmacol Exp Ther 239:32-37 (1986).
32. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ, Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275 (1951).
33. Bylund DB, Yamaura HI, Methods for receptor binding. In: Methods in Neurotransmitter Receptor Analysis (Yamaura HI, Enna SJ, Kuhar MJ, eds). New York:Raven Press, 1990;1-36.
34. Rossi AD, Zhivotovsky B, Manzo L, Vather M, Orrenius S, Nicotera P. Methylmercury Treatment Enhances NMDA Toxicity in Rat Cerebellar Granule Neurons from Offspring [PhD thesis]. Stockholm, Sweden:Karolinska lnstitutet, 1996.
35. 2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115-1117 (1985).
36. Berlin M, Ullberg S. Accumulation and retention of mercury in the mouse. I: An autoradiographic study after a single intravenous injection of mercuric chloride. Arch Environ Health 6:589-601 (1963).
37. Berlin M, Ullberg S. Accumulation and retention of mercury in the mouse. II: An autoradiographic comparison of phenylmercuric acetate with inorganic mercury. Arch Environ Health 6:602-609 (1963).
38. Berlin M, Ullberg S. Accumulation and retention of mercury in the mouse. III: An autoradiographic comparison of methyl mercuric dicyandiamide with inorganic mercury Arch Environ Health 6:610-616 (1963).
39. Thomas DJ, Fisher HL, Sumler MR, Marcus AH, Mushak P, Hall LL. Sexual differences in the distribution and retention of organic and inorganic mercury in methyl mercury-treated rats. Environ Res 41:219-234 (1986).
40. Magos L, Butler WH. The kinetics of methylmercury administered repeatedly to rats. Arch Toxicol 35:25-39 (1976).
41. Duman RS, Heninger GR, Nestler EJ. Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress-and drug-induced neural plasticity. J Nerv Ment Dis 182:692-700 (1994).
42. Schlumpf M, Palacios JM, Cortez R, Lichtensteiger W. Regional development of muscarinic cholinergic binding in the prenatal rat brain. Neuroscience 45:347-357 (1991).
43. Balduini W, Murphy SD, Costa LG. Developmental changes in muscarinic receptor-stimulated phosphoinositide metabolism in rat brain. J Pharmacol Exp Ther 241:421-427 (1987).
44. Lee W, Nicklaus KJ, Manning DR, Wolfe BB. Ontogeny of cortical muscarinic receptor subtypes and muscarinic receptor-mediated responses in rat. J Pharmacol Exp Ther 252:482-490 (1990).
45. Manzo L, Artigas F, Martinez E, Mutti A, Bergamaschi E, Nicotera P, Tonini M, Candura SM, Ray DE, Costa LG. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol 15(suppl 1):S20-S35 (1996).
46. Costa LG, Manzo L. Biomarkers in Occupational Neurotoxicology. In: Occupational Neurotoxicology (Costa LG, Manzo L, eds). Boca Raton, FL:CRC Press, 1998:75-100.
47. Ortega HG, Lopez M, Selvaggio JE, Reimers R, Hsiao-Lin C, Bollinger JE, George W. Lymphocyte proliferative response and tissue distribution of methylmercury sulfide and chloride in exposed rats. J Toxicol Environ Health 50:605-616 (1997).
48. Hulme EC, Birsdall NJM, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673 (1990).
49. Costa P, Traver DJ, Auger CB, Costa LG. Expression of cholinergic muscarinic receptor subtypes mRNA in rat blood mononuclear cells, Immunopharmacology 28:113-123 (1994).
50. Hellstrom-Lindahl E, Nordberg A. Muscarinic receptor subtypes in subpopulations of human blood mononuclear cells as analyzed by RT-PCR technique. J Neuroimmunol 68:139-144 (1996).
51. Hultman P, Hansson-Georgiadis H. Methylmercury-induced autoimmunity in mice. Toxicol Appl Pharmacol 154:203-211 (1999).
52. Rinner I, Felsner P, Falus A, Skreiner E, Kukulansky T, Globerson A, Hirokawa K, Schauenstein K. Cholinergic signals to and from the immune system. Immunol Lett 44:217-220 (1995).